Badheeb Ahmed M, Alkhanbashi Omar, Al Hammadi Shehab S, Ahmed Faisal, Guzailan Hasan, Baslasel Omar S, Bin Dahman Lotfi, Alyami Nasher H, Abu Bakar Abdullah, Badheeb Mohamed
Medicine, Hadhramout University, Mukalla, YEM.
Oncology, King Khalid Hospital - Oncology Center, Najran, SAU.
Cureus. 2024 May 9;16(5):e59992. doi: 10.7759/cureus.59992. eCollection 2024 May.
Carcinosarcoma or sarcomatoid carcinoma of the urinary bladder is a rare but aggressive bladder cancer characterized by malignant epithelial and mesenchymal components, with only a few cases reported in the literature so far. In this report, we discuss a case of a 74-year-old female nonsmoker who presented with intermittent hematuria and passage of clots in the last four months. Radiographic images showed an irregular mass lesion (6.2 x 6 cm) in the left lateral wall of the urinary bladder near to left vesicoureteral junction. The mass was completely removed with transurethral resection of the bladder tumor (TUR-BT). Histopathological study revealed high-grade carcinosarcoma, and immunohistochemistry showed diffuse positivity for vimentin, pan-cytokeratin (CK) and CK7, epithelial membrane antigen (EMA), and CK5/6. The patient declined radical cystectomy and only agreed to receive intravesical chemotherapy (gemcitabine), and she remains alive after more than four years of follow-up. Carcinosarcoma of the urinary bladder is a rare tumor primarily affecting older people, and it is most commonly treated with radical cystectomy and different combination treatments such as chemotherapy and radiation. However, tumor resection followed by intravesical chemotherapy may be an alternative option in the early stages of bladder carcinosarcoma for some patients, thereby avoiding the need for aggressive treatments, especially for elderly patients who decline to undergo radical surgery.
膀胱肉瘤样癌或癌肉瘤是一种罕见但侵袭性强的膀胱癌,其特征为恶性上皮和间充质成分,迄今为止文献中仅报道了少数病例。在本报告中,我们讨论了一例74岁不吸烟女性患者,她在过去四个月出现间歇性血尿和血凝块排出。影像学检查显示膀胱左侧壁靠近左侧输尿管膀胱连接处有一不规则肿块病变(6.2×6厘米)。通过经尿道膀胱肿瘤切除术(TUR-BT)将肿块完全切除。组织病理学研究显示为高级别癌肉瘤,免疫组织化学显示波形蛋白、泛细胞角蛋白(CK)和CK7、上皮膜抗原(EMA)以及CK5/6弥漫阳性。患者拒绝行根治性膀胱切除术,仅同意接受膀胱内化疗(吉西他滨),经过四年多的随访,她仍然存活。膀胱癌肉瘤是一种主要影响老年人的罕见肿瘤,最常见的治疗方法是根治性膀胱切除术以及化疗和放疗等不同的联合治疗。然而,对于一些患者,在膀胱癌肉瘤早期,肿瘤切除后行膀胱内化疗可能是一种替代选择,从而避免了激进治疗的需要,特别是对于拒绝接受根治性手术的老年患者。